A Retrospective Comparative Study of Two Concentrations of Intralesional Triamcinolone Acetonide in the Treatment of Patchy Alopecia Areata on the Scalp

    Muhaidat JM, Firas Al‐Qarqaz, Yousef Khader, Alshiyab DM, Hadeel Alkofahi, Mohanad Almalekh
    From the encyclopedia
    Alopecia Areata →

    autoimmune disorder causing patchy hair loss

    Studysummary This study found that intralesional triamcinolone acetonide at both 5 mg/mL and 10 mg/mL concentrations had similar effectiveness and safety for treating patchy alopecia areata on the scalp, with no significant difference in response rates or side effects between the two dosage groups.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →